home study cme enrollment form
TRANSCRIPT
Home Study CME Enrollment Form
Program Description and Objectives: The Journal of Urology® Home StudyCourse is a comprehensive learning activity developed by a team of educa-tors, academicians and clinicians. After completing this activity, participantswill be able to assess their knowledge of urology, demonstrate an increasedknowledge base of urology, and apply the increased knowledge to improvethe quality of patient care.
Program Format: Two volumes of The Journal of Urology® are publishedannually. Each volume is comprised of 6 issues. Five clinically relevantarticles are selected by the editor to be offered for CME in each issue of TheJournal. For CME credit, the participant must read the articles and answer5 related questions on the examination; enroll in the home study program;and submit answers online at www.AUAnet.org/cme. Click on CME Test.
Accreditation: The American Urological Association (AUA) is accredited bythe Accreditation Council for Continuing Medical Education (ACCME) toprovide continuing medical education for physicians. The AUA takes respon-sibility for the content, quality, and scientific integrity of this CME activity.
Credit Designation: The American Urological Association designates thiseducational activity for a maximum of 24.00 AMA PRA Category 1 Credits™.Completion of each test and a score of 80% or above qualify for 2.00 creditsof AMA PRA Category 1 Credits™ with up to a maximum of 24.00 creditsannually. Physicians should only claim credit commensurate with the extentof their participation in the activity.
Original lessons of The Journal of Urology® created and released: 2009;expires: month, 2012.
Target Audience: This home study program is designed for practicing phy-sicians, Board candidates and/or residents.
AUA Disclosure Policy: As a provider accredited by the ACCME, the AUA mustinsure balance, independence, objectivity and scientific rigor in all its activities.
All faculty participating in an educational activity provided by the AUA arerequired to disclose to the audience any relevant financial relationships withany commercial interest to the provider. The intent of this disclosure is not toprevent faculty with relevant financial relationships from serving as faculty, butrather to provide members of the audience with information on which they canmake their own judgments. The AUA must resolve any conflicts of interest prior
to the commencement of the educational activity. It remains for the audience todetermine if the faculty’s relationships may influence the educational contentFax: 1-410-689-3937
0022-5347/09/1811-0424/0THE JOURNAL OF UROLOGY®
Copyright © 2009 by AMERICAN UROLOGICAL ASSOCIATION
424 www.jurology.com
with regard to exposition or conclusion. When unlabeled or unapproved uses ofdrugs or devices are discussed, these are also indicated.
Unlabeled or Unapproved Use of Drugs or Devices: It is the policy of theAUA to require the disclosure of all references to unlabeled or unapproved usesor drugs or devices prior to the presentation of educational content. The audi-ence is advised that this continuing medical education activity may containreference(s) to unlabeled or unapproved uses of drugs or devices. Please consultthe prescribing information for full disclosure of approved uses.
Evidence-Based Content: As a provider of continuing medical educationaccredited by the ACCME, it is the policy of the AUA to review and certifythat the content contained in this CME activity is valid, fair, balanced,scientifically rigorous, and free of commercial bias.
Disclaimer: The opinions and recommendations expressed by faculty, au-thors, and other experts whose input is included in this program are theirown and do not necessarily represent the viewpoint of the AUA.
Copyright: © American Urological Association, 2009
System Requirements for Online Test: Windows PC (Windows XP or aboverecommended) or Apple Macintosh computer. Internet access. A current versionweb browser (Internet Explorer recommended) with JavaScript enabled.
AUA Privacy and Confidentiality Policy: http://www.auanet.org/cme/onlineeduconf.cfm
Program Enrollment: There are 3 convenient ways to enroll in The Journalof Urology® Home Study Course.
● Complete the form below and return by MAIL including a check or creditcard information
● Complete the form below and return by FAX including your credit cardinformation
● Enroll online at www.auanet.org. Select The Journal of Urology®. Youwill need your AUA identification number, password and credit card topurchase this home study product.
The cost for the home study is $60 per year for 2007 to 2010, which includesvolumes 181 to 188. Previous home study volumes may be ordered by calling1-866-746-4282, ext 3747.
Email the AUA Office of Education with any questions at [email protected] [email protected].
The Journal of Urology® Home Study Course Enrollment Form
Volume #$60 subscription cost per year includes online posttest
Maximum of 24 AMA PRA Category 1 Credits™ annually
Name:
Address:
City: State: Zip:
( ) Check enclosed for $ payable to: American Urological Association Education and Research, Inc.
Charge to ( ) VISA ( ) MasterCard ( ) AMEX
Card Number: Exp. Date:
Signature:
Please mail or fax registration form to: American Urological Association Education and Research, Inc.1000 Corporate Blvd.Linthicum, MD 21090Telephone: 1-410-689-3934
Vol. 181, 424-425, January 2009Printed in U.S.A.
DOI:10.1016/j.juro.2008.10.072
425
CME QUESTIONS FOR JANUARY 2009 ISSUE OF THE JOURNAL OF UROLOGY®
1. EFFECTIVENESS OF ANTIBIOTICS GIVEN TO ASYMPTOMATIC MEN FOR INCREASED PROSTATE SPE-CIFIC ANTIGEN (vol. 181, pp. 128–132)
The prostate cancer percentage in men with prostate specific antigen levels between 4 and 10 ng/ml is:
a) 0% to 10%b) 10% to 20%c) 20% to 30%d) 30% to 40%e) 40% to 50%
2. ASSESSMENT OF THE PERFORMANCE OF THE AMERICAN UROLOGICAL ASSOCIATION SYMPTOMSCORE IN 2 DISTINCT PATIENT POPULATIONS (vol. 181, pp. 230–237)
Which of the following are considered optional by the American Urological Association according to its benignprostatic hyperplasia guidelines?
a) historyb) uroflowc) digital rectal examinationd) physical examinatione) American Urological Association Symptom Score
3. DEFINING INCREASED FUTURE RISK FOR PROSTATE CANCER: EVIDENCE FROM A POPULATIONBASED SCREENING COHORT (vol. 181, pp. 69–74)
Which of the following predictive factors does not elevate a man’s future risk of a prostate cancer diagnosis?
a) a prostate specific antigen of 2.0 versus 1.0 ng/mlb) a previous prostate biopsy negative for prostate cancerc) a family history of prostate cancer in a first-degree relatived) a prostate volume of 20 versus 60 cce) African-American ethnicity
4. SYNCHRONOUS BILATERAL PERCUTANEOUS NEPHROSTOLITHOTOMY: ANALYSIS OF CLINICAL OUT-COMES, COST AND SURGEON REIMBURSEMENT (vol. 181, pp. 149–153)
Compared to staged bilateral percutaneous nephrostolithotomy, synchronous (single anesthesia) bilateral percuta-neous nephrostolithotomy is associated with which of the following outcomes?
a) increased direct costb) longer hospital length of stayc) higher physician reimbursementd) shorter cumulative operating room timee) higher transfusion rate
5. VALUE OF SERUM ANTISPERM ANTIBODIES IN DIAGNOSING OBSTRUCTIVE AZOOSPERMIA (vol. 181,pp. 264–269)
Which immunoglobulin subtype is most useful in noninvasively diagnosing obstructive azoospermia?
a) IgMb) IgAc) IgGd) IgEe) a and b
Publication date: January 2009
Expiration date: January 2012